Whalesbook
Toh bhai, yeh jo 8 stocks ki list bani hai na, yeh sab technical charts par ekdum solid signal de rahe hain. Analysts keh rahe hain ki yeh consolidation patterns, double-bottoms, aur upward channels se breakout dikha rahe hain. Isse pata chalta hai ki inmein naya dum aa gaya hai aur investors ka interest phir se jag raha hai.
AGI Infra, Crompton Greaves Consumer Electricals, aur Nazara Technologies toh khas hain, kyuki inke volumes bhi badh rahe hain aur yeh apne important moving averages ke upar trade kar rahe hain. Zydus Lifesciences aur KIMS mein bhi trend reversal ke signs dikh rahe hain.
Lekin haalanki yeh stocks akele mein perform kar rahe hain, thoda sa broader market ka bhi dekhna padega. Pata hai, 15 May ko hamare benchmark indices lagbhag 0.2% neeche gire the, aur advancers se zyada decliners the. Toh pura market abhi thoda conservative mode mein hai.
Ab in companies ke numbers dekhte hain. AGI Infra around ₹425 par hai, P/E hai 25x ke aas paas, jo infrastructure sector ke hisaab se theek lag raha hai. Zydus Lifesciences ₹1020 ke paas, P/E lagbhag 30x, pharma sector ke competitors jaise Sun Pharma, Cipla ke barabar. Crompton Greaves ₹305 par, P/E 40x, jo competitor Havells (35x) se thoda zyada hai, kyunki consumer durables sector economic cycles par depend karta hai.
KIMS ₹770 par, P/E 35x, Apollo Hospitals (45x) jaise bade players se kam. Nazara Technologies, jo gaming sector mein hai, ₹300 par, EV/Sales ratio 8x hai. Man Industries India ₹570 par, P/E 15x, Welspun Corp (12x) se behtar lag raha hai aur debt bhi moderate hai. Marksans Pharma ₹210 par, P/E 20x, Laurus Labs (25x) se neeche. Aur Rainbow Children's Medicare ₹1350 par, P/E 40x, jo dusre hospital chains ke barabar hai.
Analysts ko lagta hai ki AGI Infra ₹465 tak ja sakta hai aur Rainbow Children's Medicare ₹1641 tak. Lekin kuch ka P/E, jaise Crompton Greaves aur Rainbow ka, market average se high lag raha hai. Iska matlab hai ki ho sakta hai technical strength mein future growth already price in ho gaya ho.
Par bhai, sab kuch itna bhi smooth nahi hai. Kuch investors ko risks ka dar hai. Jaise maine bataya, 15 May ko market gir gaya tha, aur NSE par 1,914 stocks giren the jabki sirf 1,016 advance hue. Crompton Greaves ka 40x P/E thoda overvalued lag sakta hai agar growth slow ho gayi. Nazara Technologies gaming sector mein hai jo volatile hota hai, regulatory issues bhi ho sakte hain. Zydus aur KIMS ko steady demand hai healthcare mein, par pricing pressures aur competition badh sakti hai. Man Industries infrastructure spending par depend karta hai, jismein govt policy change ho sakti hai. Marksans Pharma supply chains par depend karta hai, jismein global issues aa sakte hain.
Ab targets ki baat karein toh AGI Infra ke liye ₹440 aur ₹465 ke targets hain. Crompton Greaves ke liye ₹320 aur ₹335. Zydus Lifesciences ₹1060 se ₹1120 tak ja sakta hai. Man Industries India ₹620 tak, KIMS ₹820 tak. Marksans Pharma ke liye ₹220 aur ₹225. Rainbow Children's Medicare ka immediate target ₹1388 hai, aur bada target ₹1641. Nazara Technologies ₹340 zone tak ja sakta hai.
Yeh sab targets tabhi achieve honge jab technical trends aur market conditions support karein. Lekin analysts ne stop-loss levels bhi diye hain, jaise Nazara Technologies ke liye ₹275 se lekar Rainbow Children's Medicare ke liye ₹1250 tak. Isse pata chalta hai ki yeh sab short-term trading ideas hain aur risk bhi hai.